Ads
related to: cataract surgery
Search results
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Rating of “Buy” from Brokerages
ETF DAILY NEWS· 2 days agoRxSight, Inc. (NASDAQ:RXST – Get Free Report) has been given a consensus rating of “Buy” by the seven ratings firms that are covering the stock, Marketbeat reports. Seven equities research analysts ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoPRESS RELEASE BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage The seed round was co-led by UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity